Publications

Publications from OUS - Dept of Infect.Dis. RG Chronic Infections

327 publications found

Publications 2025

1. Dahl TB, Aftab F, Prebensen C, Berdal JE, Ueland T, Barratt-Due A, Riise AMD, Ueland PM, Hov JR, Trøseid M, Aukrust P, Gregersen I, Myhre PL, Omland T, Halvorsen B (2025)
   Imidazole propionate is increased in severe COVID-19 and correlates with cardiac involvement
   J Infect, 90 (6), 106494 (in press)
   DOI 10.1016/j.jinf.2025.106494, PubMed 40280497
2. Kirakosyan O, Reimann M, Andersen AB, Bjarnason A, Bakos Á, Dyrhol-Riise AM, McLaughlin AM, Nita C, Pieridou D, Chesov D, Davidavičienė EV, Günther G, Atshemyan H, Muylle I, Solovic I, Bruchfeld J, Manika K, Kuksa L, Codecasa LR, Stosic M, Skowroński M, Makek MJ, Fréchet Jachym M, Knappik M, Santin M et al. (2025)
   Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe
   IJTLD Open, 2 (2), 101-106
   DOI 10.5588/ijtldopen.24.0498, PubMed 39959402
3. Skarpengland T, Tveita AA, Berntsen CF, Christensen EE, Macpherson ME, Stiksrud B, Hermansen NO, Niehusmann P, Oldereid TS, Stjernstrøm E, Brekke H, Nielsen HV, Pettersen FOD (2025)
   Neurosarcocystosis in Patient with HIV-Induced Immunodeficiency
   Emerg Infect Dis, 31 (3), 617-619
   DOI 10.3201/eid3103.241361, PubMed 40023823

Publications 2024

1. Alirezaylavasani A, Skeie LG, Egner IM, Chopra A, Dahl TB, Prebensen C, Vaage JT, Halvorsen B, Lund-Johansen F, Tonby K, Reikvam DH, Stiksrud B, Holter JC, Dyrhol-Riise AM, Munthe LA, Kared H (2024)
   Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections
   NPJ Vaccines, 9 (1), 185
   DOI 10.1038/s41541-024-00972-3, PubMed 39384763
2. Alonso-Rodríguez N, Vianello E, van Veen S, Jenum S, Tonby K, van Riessen R, Lai X, Mortensen R, Ottenhoff THM, Dyrhol-Riise AM (2024)
   Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy
   Front Immunol, 15, 1350593
   DOI 10.3389/fimmu.2024.1350593, PubMed 38433842
3. Barratt-Due A, Pettersen K, Børresdatter-Dahl T, Holter JC, Grønli RH, Dyrhol-Riise AM, Lerum TV, Holten AR, Tonby K, Trøseid M, Skjønsberg OH, Granerud BK, Heggelund L, Kildal AB, Schjalm C, Aaløkken TM, Aukrust P, Ueland T, Mollnes TE, Halvorsen B, NOR‐Solidarity study groupThe Norwegian SARS‐CoV‐2 study group (2024)
   Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients
   J Intern Med, 296 (1), 80-92
   DOI 10.1111/joim.13783, PubMed 38539241
4. Brantsæter AB (2024)
   Doctors should not shake the hands of patients
   Tidsskr Nor Laegeforen, 144 (9)
   DOI 10.4045/tidsskr.24.0382, PubMed 39166989
5. Brantsæter AB, Hansen AE, Gustavsen AG, Stensvåg V, Aastrøm HA, Heyerdahl F, Tveitane PM, Nakstad ER (2024)
   Transport of Patients With High-Consequence Infectious Diseases: Development of European Capacity in Norway
   Health Secur, 22 (S1), S76-S85
   DOI 10.1089/hs.2023.0153, PubMed 39137054
6. Grønmo MM, Møller-Stray J, Akselsen PE, Lindemann PC, Fostervold A, Knudsen CV, Knudsen PK, Lindbæk M, Tonby K, Sundsfjord A (2024)
   Gentamicin should remain part of the empirical sepsis regimen for adults
   Tidsskr Nor Laegeforen, 144 (3)
   DOI 10.4045/tidsskr.23.0659, PubMed 38415563
7. Halvorsen B, Viermyr HK, Ueland T, Sagen EL, Michelsen AE, Bjerkeli V, Nor-Solidarity Study Group, Tveita AA, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Trøseid M, Dahl TB, Aukrust P, Gregersen I (2024)
   IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement
   J Infect, 89 (1), 106176
   DOI 10.1016/j.jinf.2024.106176, PubMed 38719108
8. Hites M, Massonnaud CR, Lapique EL, Belhadi D, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Moing VL, Piroth L, Sellier P et al. (2024)
   Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
   J Infect, 88 (3), 106120
   DOI 10.1016/j.jinf.2024.106120, PubMed 38367705
9. Hoel H, Dahl TB, Yang K, Skeie LG, Michelsen AE, Ueland T, Damås JK, Dyrhol-Riise AM, Fevang B, Yndestad A, Aukrust P, Trøseid M, Sandanger Ø (2024)
   Chronic HIV Infection Increases Monocyte NLRP3 Inflammasome-Dependent IL-1α and IL-1β Release
   Int J Mol Sci, 25 (13)
   DOI 10.3390/ijms25137141, PubMed 39000248
10. Kraef C, Singh S, Fursa O, Abutidze A, Rukhadze N, Mulabdic V, Yancheva N, Mehmeti M, Balayan T, Harxhi A, Trajanovska J, Mackintosh C, Duvivier C, Beniowski M, Jilich D, Reikvam DH, Tau L, Podlekareva D, Ryom L, Peters L, Kowalska J, Kirk O, EuroSIDA Study Group (2024)
    Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European region
    HIV Med, 25 (6), 700-710
    DOI 10.1111/hiv.13619, PubMed 38361216
11. Markussen DL, Wathne JS, Ritz C, van Werkhoven CH, Serigstad S, Bjørneklett RO, Ulvestad E, Knoop ST, Jenum S, Grewal HMS (2024)
    Determinants of non-adherence to antibiotic treatment guidelines in hospitalized adults with suspected community-acquired pneumonia: a prospective study
    Antimicrob Resist Infect Control, 13 (1), 140
    DOI 10.1186/s13756-024-01494-2, PubMed 39580437
12. Mortensen R, Clemmensen HS, Woodworth JS, Therkelsen ML, Mustafa T, Tonby K, Jenum S, Agger EM, Dyrhol-Riise AM, Andersen P (2024)
    Author Correction: Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
    Commun Biol, 7 (1), 662
    DOI 10.1038/s42003-024-06260-z, PubMed 38811662
13. Murphy SL, Balzer NR, Ranheim T, Sagen EL, Huse C, Bjerkeli V, Michelsen AE, Finbråten AK, Heggelund L, Dyrhol-Riise AM, Tveita A, Holten AR, Trøseid M, Ueland T, Ulas T, Aukrust P, Barratt-Due A, Halvorsen B, Dahl TB (2024)
    Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study
    Front Immunol, 15, 1379570
    DOI 10.3389/fimmu.2024.1379570, PubMed 38957465
14. Nore KG, Louet C, Bugge M, Gidon A, Jørgensen MJ, Jenum S, Dyrhol-Riise AM, Tonby K, Flo TH (2024)
    The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth
    J Infect Dis, 229 (3), 888-897
    DOI 10.1093/infdis/jiad390, PubMed 37721470
15. Patrick-Brown TDJH, Barratt-Due A, Trøseid M, Dyrhol-Riise AM, Nezvalova-Henriksen K, Kåsine T, Aukrust P, Olsen IC, NOR Solidarity consortium (2024)
    The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
    Commun Med (Lond), 4 (1), 231
    DOI 10.1038/s43856-024-00650-4, PubMed 39533001
16. Sivakumaran D, Jenum S, Markussen DL, Serigstad S, Srivastava A, Saghaug CS, Ulvestad E, Knoop ST, Grewal HMS (2024)
    Protein and transcriptional biomarker profiling may inform treatment strategies in lower respiratory tract infections by indicating bacterial-viral differentiation
    Microbiol Spectr, 12 (10), e0283123
    DOI 10.1128/spectrum.02831-23, PubMed 39269158
17. Viermyr HK, Halvorsen B, Sagen EL, Michelsen AE, Barrat-Due A, Kåsine T, Nezvalova-Henriksen K, Dyrhol-Riise AM, Nor‐Solidarity Consortium, Lerum TV, Müller F, Tonby K, Tveita A, Aukrust P, Trøseid M, Ueland T, Dahl TB (2024)
    High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial
    J Intern Med, 296 (3), 249-259
    DOI 10.1111/joim.13820, PubMed 39011800
18. Viermyr HK, Tonby K, Ponzi E, Trouillet-Assant S, Poissy J, Arribas JR, Dyon-Tafani V, Bouscambert-Duchamp M, Assoumou L, Halvorsen B, Tekin NB, Diallo A, De Gastines L, Munthe LA, Murphy SL, Ueland T, Michelsen AE, Lund-Johansen F, Aukrust P, Mootien J, Dervieux B, Zerbib Y, Richard JC, Prével R, Malvy D et al. (2024)
    Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial
    EBioMedicine, 111, 105511
    DOI 10.1016/j.ebiom.2024.105511, PubMed 39731852

Publications 2023

1. Abdelhak A, Barba L, Romoli M, Benkert P, Conversi F, D'Anna L, Masvekar RR, Bielekova B, Prudencio M, Petrucelli L, Meschia JF, Erben Y, Furlan R, De Lorenzo R, Mandelli A, Sutter R, Hert L, Epple V, Marastoni D, Sellner J, Steinacker P, Aamodt AH, Heggelund L, Dyrhol-Riise AM, Virhammar J et al. (2023)
   Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis
   J Neurol, 270 (7), 3315-3328
   DOI 10.1007/s00415-023-11768-1, PubMed 37184659
2. Christensen EE, Prebensen CH, Martinsen AB, Stiff ET, Hoff R, Kvale D, Holten AR (2023)
   Mortality and Sequential Organ Failure Assessment Score in Patients With Suspected Sepsis: The Impact of Acute and Preexisting Organ Failures and Infection Likelihood
   Crit Care Explor, 5 (2), e0865
   DOI 10.1097/CCE.0000000000000865, PubMed 36844375
3. Gunst JD, Højen JF, Pahus MH, Rosás-Umbert M, Stiksrud B, McMahon JH, Denton PW, Nielsen H, Johansen IS, Benfield T, Leth S, Gerstoft J, Østergaard L, Schleimann MH, Olesen R, Støvring H, Vibholm L, Weis N, Dyrhol-Riise AM, Pedersen KBH, Lau JSY, Copertino DC, Linden N, Huynh TT, Ramos V et al. (2023)
   Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
   Nat Med, 29 (10), 2547-2558
   DOI 10.1038/s41591-023-02547-6, PubMed 37696935
4. Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
   A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
   Hepatology, 77 (3), 715-728
   DOI 10.1002/hep.32773, PubMed 36056902
5. Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
   Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
   Hepatology, 77 (6), E188-E189
   DOI 10.1097/HEP.0000000000000340, PubMed 36815351
6. Holmberg M, Aass HCD, Dalgard O, Samuelsen E, Sun D, Björkström NK, Johannessen A, Reikvam DH (2023)
   Treatment cessation in HBeAg-negative chronic hepatitis B: clinical response is associated with increase in specific proinflammatory cytokines
   Sci Rep, 13 (1), 22590
   DOI 10.1038/s41598-023-50216-y, PubMed 38114718
7. Holten AR, Skrede S (2023)
   [Early antibiotic treatment for the right patients]
   Tidsskr Nor Laegeforen, 143 (2)
   DOI 10.4045/tidsskr.22.0702, PubMed 36718892
8. Lefol Y, Korfage T, Mjelle R, Prebensen C, Lüders T, Müller B, Krokan H, Sarno A, Alsøe L, CONSORTIUM LEMONAID, Berdal JE, Sætrom P, Nilsen H, Domanska D (2023)
   TiSA: TimeSeriesAnalysis-a pipeline for the analysis of longitudinal transcriptomics data
   NAR Genom Bioinform, 5 (1), lqad020
   DOI 10.1093/nargab/lqad020, PubMed 36879899
9. Lundgren JD, Babiker AG, Sharma S, Grund B, Phillips AN, Matthews G, Kan VL, Aagaard B, Abo I, Alston B, Arenas-Pinto A, Avihingsanon A, Badal-Faesen S, Brites C, Carey C, Casseb J, Clarke A, Collins S, Corbelli GM, Dao S, Denning ET, Emery S, Eriobu N, Florence E, Furrer H et al. (2023)
   Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection
   NEJM Evid, 2 (3)
   DOI 10.1056/evidoa2200302, PubMed 37213438
10. Markussen DL, Ebbesen M, Serigstad S, Knoop ST, Ritz C, Bjørneklett R, Kommedal Ø, Jenum S, Ulvestad E, Grewal HMS (2023)
    The diagnostic utility of microscopic quality assessment of sputum samples in the era of rapid syndromic PCR testing
    Microbiol Spectr, 11 (5), e0300223 (in press)
    DOI 10.1128/spectrum.03002-23, PubMed 37772853
11. Mohn KG, Bredholt G, Onyango TB, Brokstad KA, Zhou F, Holter JC, Tonby K, Dyrhol-Riise AM, Cox RJ, Bergen COVID-19 Research Group, Norwegian SARS-CoV-2 Study Group (2023)
    SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
    J Infect, 87 (4), 346-349
    DOI 10.1016/j.jinf.2023.05.023, PubMed 37295510
12. Murphy SL, Halvorsen B, Holter JC, Huse C, Tveita A, Trøseid M, Hoel H, Kildal AB, Holten AR, Lerum TV, Skjønsberg OH, Michelsen AE, Aaløkken TM, NOR-SOLIDARITY Consortium, The Norwegian SARS-CoV-2 study group investigators, Tonby K, Lind A, Dudman S, Granerud BK, Heggelund L, Bøe S, Dyrholt-Riise AM, Aukrust P, Barratt-Due A, Ueland T, Dahl TB (2023)
    Circulating markers of extracellular matrix remodelling in severe COVID-19 patients
    J Intern Med, 294 (6), 784-797
    DOI 10.1111/joim.13725, PubMed 37718572
13. Nissen-Meyer LSH, Macpherson ME, Skeie LG, Hvalryg M, Llohn AH, Steinsvåg TT, Fenstad MH, Tveita A, Kristoffersen EK, Sundic T, Lund-Johansen F, Vaage JT, Flesland Ø, Dyrhol-Riise AM, Holter JC, Hervig TA, Fevang B (2023)
    COVID-19 patients treated with convalescent plasma
    Tidsskr Nor Laegeforen, 143 (11)
    DOI 10.4045/tidsskr.22.0577, PubMed 37589359
14. Prebensen C, Lefol Y, Myhre PL, Lüders T, Jonassen C, Blomfeldt A, Omland T, Nilsen H, Berdal JE (2023)
    Longitudinal whole blood transcriptomic analysis characterizes neutrophil activation and interferon signaling in moderate and severe COVID-19
    Sci Rep, 13 (1), 10368
    DOI 10.1038/s41598-023-37606-y, PubMed 37365222
15. Prebensen C, Lefol Y, Myhre PL, Lüders T, Jonassen C, Blomfeldt A, Omland T, Nilsen H, Berdal JE (2023)
    Author Correction: Longitudinal whole blood transcriptomic analysis characterizes neutrophil activation and interferon signaling in moderate and severe COVID-19
    Sci Rep, 13 (1), 12691
    DOI 10.1038/s41598-023-39872-2, PubMed 37542160
16. Quiles-Jiménez A, Sousa MML, Huse C, Dyrhol-Riise AM, Holter JC, Christensen EE, Tonby K, Holten AR, Aukrust P, Bjørås M, Dahl TB, Halvorsen B (2023)
    Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome
    J Infect, 86 (6), 593-595
    DOI 10.1016/j.jinf.2023.03.002, PubMed 36889510
17. Sivakumaran D, Jenum S, Srivastava A, Steen VM, Vaz M, Doherty TM, Ritz C, Grewal HMS (2023)
    Host blood-based biosignatures for subclinical TB and incipient TB: A prospective study of adult TB household contacts in Southern India
    Front Immunol, 13, 1051963
    DOI 10.3389/fimmu.2022.1051963, PubMed 36713386
18. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655
19. Trøseid M, Holter JC, Holm K, Vestad B, Sazonova T, Granerud BK, Dyrhol-Riise AM, Holten AR, Tonby K, Kildal AB, Heggelund L, Tveita A, Bøe S, Müller KE, Jenum S, Hov JR, Ueland T, Norwegian SARS-CoV-2 study group (2023)
    Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
    Crit Care, 27 (1), 69
    DOI 10.1186/s13054-023-04356-2, PubMed 36814280
20. Ueland T, Michelsen AE, Tveita AA, Kåsine T, Dahl TB, Finbråten AK, Holten AR, Skjønsberg OH, Mathiessen A, Henriksen KN, Trøseid M, Aaløkken TM, Halvorsen B, Dyrhol-Riise AM, Barratt-Due A, Aukrust P (2023)
    Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial
    Res Pract Thromb Haemost, 8 (1), 102289
    DOI 10.1016/j.rpth.2023.102289, PubMed 38292350
21. Ueland T, Äikäs LAO, Dahl TB, Gregersen I, Olsen MB, Michelsen A, Schanke Y, Holopainen M, Ruhanen H, Singh S, NOR-SOLIDARITY Consortium, Tveita AA, Finbråten AK, Heggelund L, Trøseid M, Dyrhol-Riise AM, Nyman TA, Holven KB, Öörni K, Aukrust P, Halvorsen B (2023)
    Low-density lipoprotein particles carrying proinflammatory proteins with altered aggregation pattern detected in COVID-19 patients 3 months after hospitalization
    J Infect, 86 (5), 489-492
    DOI 10.1016/j.jinf.2023.02.024, PubMed 36822413

Publications 2022

1. Chendi BH, Jooste T, Scriba TJ, Kidd M, Mendelsohn S, Tonby K, Walzl G, Dyrhol-Riise AM, Chegou NN (2022)
   Utility of a three-gene transcriptomic signature in the diagnosis of tuberculosis in a low-endemic hospital setting
   Infect Dis (Lond), 55 (1), 44-54
   DOI 10.1080/23744235.2022.2129779, PubMed 36214761
2. Christensen EE, Binde C, Leegaard M, Tonby K, Dyrhol-Riise AM, Kvale D, Amundsen EK, Holten AR (2022)
   DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT
   Shock, 58 (4), 251-259
   DOI 10.1097/SHK.0000000000001981, PubMed 36130401
3. Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, Uellendahl-Werth F, ElAbd H, Rühlemann MC, Arora J, Özer O, Lenning OB, Myhre R, Vadla MS, Wacker EM, Wienbrandt L, Blandino Ortiz A, de Salazar A, Garrido Chercoles A, Palom A, Ruiz A, Garcia-Fernandez AE, Blanco-Grau A, Mantovani A, Zanella A et al. (2022)
   Detailed stratified GWAS analysis for severe COVID-19 in four European populations
   Hum Mol Genet, 31 (23), 3945-3966
   DOI 10.1093/hmg/ddac158, PubMed 35848942
4. Gohli J, Anderson AM, Brantsaeter AB, Bøifot KO, Grub C, Hadley CL, Lind A, Pettersen ES, Søraas AVL, Dybwad M (2022)
   Dispersion of SARS-CoV-2 in air surrounding COVID-19-infected individuals with mild symptoms
   Indoor Air, 32 (2), e13001
   DOI 10.1111/ina.13001, PubMed 35225394
5. Gohli J, Brantsæter AB, Bøifot KO, Grub C, Granerud BK, Holter JC, Riise AMD, Smedholen MF, Dybwad M (2022)
   SARS-CoV-2 in the Air Surrounding Patients during Nebulizer Therapy
   Can J Infect Dis Med Microbiol, 2022, 9297974
   DOI 10.1155/2022/9297974, PubMed 36213437
6. Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B, NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators (2022)
   CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19
   J Infect, 85 (6), 702-769
   DOI 10.1016/j.jinf.2022.09.029, PubMed 36216188
7. Leiva RA, Bergersen BM, Finbråten AK, Sandvei PK, Simonsen Ø, Rosseland CM, Hagen K, Young L, Roberts RS, Mikkelsen Y, Singh R, Lagging M, Dalgard O (2022)
   High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway
   Scand J Gastroenterol, 58 (3), 264-268
   DOI 10.1080/00365521.2022.2118555, PubMed 36063075
8. Lekva T, Ueland T, Halvorsen B, Murphy SL, Dyrhol-Riise AM, Tveita A, Finbråten AK, Mathiessen A, Müller KE, Aaløkken TM, Skjønsberg OH, Lerum TV, Aukrust P, Dahl TB (2022)
   Markers of cellular senescence is associated with persistent pulmonary pathology after COVID-19 infection
   Infect Dis (Lond), 54 (12), 918-923
   DOI 10.1080/23744235.2022.2113135, PubMed 35984738
9. Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
   Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
   J Infect Dis, 225 (4), 661-674
   DOI 10.1093/infdis/jiaa714, PubMed 33216130
10. Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
    Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
    J Acquir Immune Defic Syndr, 89 (1), 77-86
    DOI 10.1097/QAI.0000000000002817, PubMed 34878437
11. Murphy SL, Halvorsen B, Barratt-Due A, Dyrhol-Riise AM, Aukrust P, Trøseid M, Dahl TB (2022)
    Remdesivir modifies interferon response in hospitalized COVID-19 patients
    J Infect, 85 (5), 573-607
    DOI 10.1016/j.jinf.2022.07.021, PubMed 35914611
12. Nikolaichuk M, Mocroft A, Wandeler G, Szlavik J, Gottfredsson M, Reikvam DH, Svedhem V, Elinav H, Laguno M, Mansinho K, Devitt E, Chkhartishvili N, Behrens G, Bogner J, Viard JP, Winston A, Benfield T, Leen C, Fursa O, Rockstroh J, Peters L, EuroSIDA study group (2022)
    Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study
    HIV Med, 24 (2), 224-230
    DOI 10.1111/hiv.13357, PubMed 35934954
13. Olsen MB, Huse C, de Sousa MML, Murphy SL, Sarno A, Obermann TS, Yang K, Holter JC, Jørgensen MJ, Christensen EE, Wang W, Ji P, Heggelund L, Hoel H, Dyrhol-Riise AM, Gregersen I, Aukrust P, Bjørås M, Halvorsen B, Dahl TB (2022)
    DNA Repair Mechanisms are Activated in Circulating Lymphocytes of Hospitalized Covid-19 Patients
    J Inflamm Res, 15, 6629-6644
    DOI 10.2147/JIR.S379331, PubMed 36514358
14. Siljan WW, Sivakumaran D, Ritz C, Jenum S, Ottenhoff TH, Ulvestad E, Holter JC, Heggelund L, Grewal HM (2022)
    Host Transcriptional Signatures Predict Etiology in Community-Acquired Pneumonia: Potential Antibiotic Stewardship Tools
    Biomark Insights, 17, 11772719221099130
    DOI 10.1177/11772719221099130, PubMed 35693251
15. Sivakumaran D, Jenum S, Ritz C, Vaz M, Doherty TM, Grewal HMS (2022)
    Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis?
    Front Immunol, 13, 801616
    DOI 10.3389/fimmu.2022.801616, PubMed 35401549
16. Trøseid M, Dahl TB, Holter JC, Kildal AB, Murphy SL, Yang K, Quiles-Jiménez A, Heggelund L, Müller KE, Tveita A, Michelsen AE, Bøe S, Holten AR, Hoel H, Mathiessen A, Aaløkken TM, Fevang B, Granerud BK, Tonby K, Henriksen KN, Lerum TV, Müller F, Skjønsberg OH, Barratt-Due A, Dyrhol-Riise AM et al. (2022)
    Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies
    J Intern Med, 292 (5), 816-828
    DOI 10.1111/joim.13549, PubMed 35982589
17. Tusch ES, Ryom L, Fursa O, Peters L, Østergaard L, Florence E, Edwards S, Hoffmann C, Sambatakou H, Reiss P, Shahar E, Reikvam DH, Schmied B, Paduta D, Yakovlev A, Szlávik J, Ranin J, Zilmer K, Uždaviniene V, Pelchen-Matthews A, Mocroft A, Reekie J (2022)
    Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV
    AIDS, 37 (1), 161-171
    DOI 10.1097/QAD.0000000000003402, PubMed 36250262
18. Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, Kaarbø M, Heggelund L, Holten AR, Finbråten AK, Müller KE, Mathiessen A, Bøe S, Fevang B, Granerud BK, Tonby K, Lind A, Dudman SG, Henriksen KN, Müller F, Skjønsberg OH, Trøseid M, Barratt-Due A, Dyrhol-Riise AM, Aukrust P et al. (2022)
    High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
    J Infect Dis, 226 (12), 2150-2160
    DOI 10.1093/infdis/jiac313, PubMed 35876699
19. Ueland T, Hausberg I, Mørtberg TV, Dahl TB, Lerum TV, Michelsen A, Ranheim T, Nezvalova Henriksen K, Dyrhol-Riise AM, Holme PA, Aaløkken TM, Skjønsberg OH, Barratt-Due A, Ahlén MT, Aukrust P, Halvorsen B (2022)
    Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology
    Platelets, 33 (4), 640-644
    DOI 10.1080/09537104.2022.2042238, PubMed 35225150
20. Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Tonby K, Hoel H, Olsen IC, Henriksen KN, Tveita A, Manotheepan R, Haugli M, Eiken R, Berg Å, Halvorsen B, Lekva T, Ranheim T, Michelsen AE, Kildal AB, Johannessen A, Thoresen L et al. (2022)
    Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations
    J Intern Med, 291 (6), 801-812
    DOI 10.1111/joim.13458, PubMed 35212063
21. Wæhre T, Tunheim G, Bodin JE, Laake I, Kvale D, Kran AB, Brekke H, Løken R, Oftung F, Mjaaland S, Dyrhol-Riise AM (2022)
    Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014-2018
    Infect Dis (Lond), 54 (5), 367-377
    DOI 10.1080/23744235.2021.2022196, PubMed 34983302
22. Wæhre T, Waagsbø B, Jordal S, Indrebø EM, Wang H, Akselsen PE (2022)
    [Consultation round: Antimicrobial treatment for sepsis]
    Tidsskr Nor Laegeforen, 142 (4)
    DOI 10.4045/tidsskr.22.0029, PubMed 35239281
23. Waagsbø B, Espvik HJ, Høgli JU, Tonby K, Kleppe LKS (2022)
    [We need a new action plan for antibiotic resistance]
    Tidsskr Nor Laegeforen, 142 (11)
    DOI 10.4045/tidsskr.22.0279, PubMed 35997193

Publications 2021

1. Amundsen EK, Binde C, Christensen EE, Klingenberg O, Kvale D, Holten AR (2021)
   Prognostic Value of Nucleated RBCs for Patients With Suspected Sepsis in the Emergency Department: A Single-Center Prospective Cohort Study
   Crit Care Explor, 3 (7), e0490
   DOI 10.1097/CCE.0000000000000490, PubMed 34291222
2. Barratt-Due A, Olsen IC, Nezvalova-Henriksen K, Kåsine T, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Kildal AB, Berg Å, Johannessen A, Heggelund L, Dahl TB, Skåra KH, Mielnik P, Le LAK, Thoresen L, Ernst G, Hoff DAL, Skudal H, Kittang BR, Olsen RB et al. (2021)
   Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial
   Ann Intern Med, 174 (9), 1261-1269
   DOI 10.7326/M21-0653, PubMed 34251903
3. Chendi BH, Snyders CI, Tonby K, Jenum S, Kidd M, Walzl G, Chegou NN, Dyrhol-Riise AM (2021)
   A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
   Front Immunol, 12, 608846
   DOI 10.3389/fimmu.2021.608846, PubMed 33732236
4. Chendi BH, Tveiten H, Snyders CI, Tonby K, Jenum S, Nielsen SD, Hove-Skovsgaard M, Walzl G, Chegou NN, Dyrhol-Riise AM (2021)
   CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries
   J Infect, 83 (4), 433-443
   DOI 10.1016/j.jinf.2021.07.036, PubMed 34333033
5. Christensen EE, Jørgensen MJ, Nore KG, Dahl TB, Yang K, Ranheim T, Huse C, Lind A, Nur S, Stiksrud B, Jenum S, Tonby K, Holter JC, Holten AR, Halvorsen B, Dyrhol-Riise AM (2021)
   Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns
   J Intern Med, 290 (3), 677-692
   DOI 10.1111/joim.13310, PubMed 34080738
6. Jenum S, Tonby K, Rueegg CS, Rühwald M, Kristiansen MP, Bang P, Olsen IC, Sellæg K, Røstad K, Mustafa T, Taskén K, Kvale D, Mortensen R, Dyrhol-Riise AM (2021)
   A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
   Nat Commun, 12 (1), 6774
   DOI 10.1038/s41467-021-27029-6, PubMed 34811370
7. Jøntvedt Jørgensen M, Nore KG, Aass HCD, Layre E, Nigou J, Mortensen R, Tasken K, Kvale D, Jenum S, Tonby K, Dyrhol-Riise AM (2021)
   Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
   Front Cell Infect Microbiol, 11, 669623
   DOI 10.3389/fcimb.2021.669623, PubMed 34307194
8. Kolberg ES, Wickstrøm K, Tonby K, Dyrhol-Riise AM, Holten AR, Amundsen EK (2021)
   Serum ACE as a prognostic biomarker in COVID-19: a case series
   APMIS, 129 (4), 237-238
   DOI 10.1111/apm.13108, PubMed 33368687
9. Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, NOR-SOLIDARITY Consortium et al. (2021)
   Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
   Sci Rep, 11 (1), 23205
   DOI 10.1038/s41598-021-02547-x, PubMed 34853380
10. Lerum TV, Aaløkken TM, Brønstad E, Aarli B, Ikdahl E, Lund KMA, Durheim MT, Rodriguez JR, Meltzer C, Tonby K, Stavem K, Skjønsberg OH, Ashraf H, Einvik G (2021)
    Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19
    Eur Respir J, 57 (4)
    DOI 10.1183/13993003.03448-2020, PubMed 33303540
11. Lorvik KB, Meyer-Myklestad MH, Kushekar K, Handeland C, Medhus AW, Lund-Iversen M, Stiksrud B, Kvale D, Dyrhol-Riise AM, Taskén K, Reikvam DH (2021)
    Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4⁺ T Cells in HIV-Infected Immunological Non-Responders
    Front Immunol, 12, 744155
    DOI 10.3389/fimmu.2021.744155, PubMed 34691047
12. Lundin KEA, Røsjø H, Myhren H, Kvale D, Rosvold EO (2021)
    [Medical education and training during a pandemic]
    Tidsskr Nor Laegeforen, 141
    DOI 10.4045/tidsskr.21.0581, PubMed 34505488
13. Nissen-Meyer LSH, Brantsæter AB (2021)
    The story of an extraordinary year: Challenges and opportunities in responding to Covid-19
    Transfus Apher Sci, 60 (2), 103092
    DOI 10.1016/j.transci.2021.103092, PubMed 33612447
14. Nydal SM, Munyaw Y, Bruun JN, Brantsæter AB (2021)
    Achievements and Challenges in the Prevention of Mother-to-Child Transmission of HIV-A Retrospective Cohort Study from a Rural Hospital in Northern Tanzania
    Int J Environ Res Public Health, 18 (5)
    DOI 10.3390/ijerph18052751, PubMed 33803114
15. Pedersen HB, Kaviyani RS, Quist-Paulsen E, Dedi L, Reikvam DH, Jenum S, Fosshaug L, Biernat D, Schwartz T (2021)
    A man in his seventies with pleural effusion, knee pain and dysarthria following open heart surgery
    Tidsskr Nor Laegeforen, 141 (18)
    DOI 10.4045/tidsskr.21.0163, PubMed 34911264
16. Sigfrid L, Cevik M, Jesudason E, Lim WS, Rello J, Amuasi J, Bozza F, Palmieri C, Munblit D, Holter JC, Kildal AB, Reyes LF, Russell CD, Ho A, Turtle L, Drake TM, Beltrame A, Hann K, Bangura IR, Fowler R, Lakoh S, Berry C, Lowe DJ, McPeake J, Hashmi M et al. (2021)
    What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol
    BMJ Open, 11 (3), e043887
    DOI 10.1136/bmjopen-2020-043887, PubMed 33692181
17. Sivakumaran D, Blatner G, Bakken R, Hokey D, Ritz C, Jenum S, Grewal HMS (2021)
    A 2-Dose AERAS-402 Regimen Boosts CD8⁺ Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients
    Front Immunol, 12, 673532
    DOI 10.3389/fimmu.2021.673532, PubMed 34177914
18. Sivakumaran D, Ritz C, Gjøen JE, Vaz M, Selvam S, Ottenhoff THM, Doherty TM, Jenum S, Grewal HMS (2021)
    Host Blood RNA Transcript and Protein Signatures for Sputum-Independent Diagnostics of Tuberculosis in Adults
    Front Immunol, 11, 626049
    DOI 10.3389/fimmu.2020.626049, PubMed 33613569
19. Ueland T, Dyrhol-Riise AM, Woll BM, Holten AR, Petteresen F, Lind A, Dudman SG, Heggelund L, Holter JC, Aukrust P (2021)
    Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients
    J Infect, 82 (5), 186-230
    DOI 10.1016/j.jinf.2021.01.017, PubMed 33516748
20. Watne LO, Tonby K, Holten AR, Olasveengen TM, Romundstad LG, Neerland BE (2021)
    Delirium is common in patients hospitalized with COVID-19
    Intern Emerg Med, 16 (7), 1997-2000
    DOI 10.1007/s11739-021-02715-x, PubMed 33830418
21. Wickstrøm KE, Vitelli V, Carr E, Holten AR, Bendayan R, Reiner AH, Bean D, Searle T, Shek A, Kraljevic Z, Teo J, Dobson R, Tonby K, Köhn-Luque A, Amundsen EK (2021)
    Regional performance variation in external validation of four prediction models for severity of COVID-19 at hospital admission: An observational multi-centre cohort study
    PLoS One, 16 (8), e0255748
    DOI 10.1371/journal.pone.0255748, PubMed 34432797
22. Aamodt AH, Høgestøl EA, Popperud TH, Holter JC, Dyrhol-Riise AM, Tonby K, Stiksrud B, Quist-Paulsen E, Berge T, Barratt-Due A, Aukrust P, Heggelund L, Blennow K, Zetterberg H, Harbo HF (2021)
    Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
    J Neurol, 268 (10), 3574-3583
    DOI 10.1007/s00415-021-10517-6, PubMed 33743046

Publications 2020

1. Bekken GK, Ritz C, Selvam S, Jesuraj N, Hesseling AC, Doherty TM, Grewal HMS, Vaz M, Jenum S (2020)
   Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations
   BMC Infect Dis, 20 (1), 96
   DOI 10.1186/s12879-020-4800-y, PubMed 32005136
2. Borén HK, Thaulow CM, Quist-Paulsen E, Wæhre T, Akselsen PE, Tonby K (2020)
   [Antibiotic use in hospitals in cases of COVID-19]
   Tidsskr Nor Laegeforen, 140 (11)
   DOI 10.4045/tidsskr.20.0443, PubMed 32815355
3. Brantsaeter AB (2020)
   Experimental treatment in COVID-19
   Tidsskr. Nor. Laegeforen., 140 (12), 1211
4. Døving M, Christensen EE, Huse LP, Vengen Ø (2020)
   A case of septic arthritis of the temporomandibular joint with necrotic peri-articular infection and Lemierre's syndrome: an unusual presentation
   Oral Maxillofac Surg, 25 (3), 411-415
   DOI 10.1007/s10006-020-00921-z, PubMed 33151408
5. Gundem T, Olasveengen TM, Hovda KE, Gaustad K, Schøndorf C, Rostrup M, Frøyshov S, Undseth Ø, Tonby K, Holten AR, Sunde K (2020)
   Ventilatory support for hypoxaemic intensive care patients with COVID-19
   Tidsskr Nor Laegeforen, 140 (11)
   DOI 10.4045/tidsskr.20.0445, PubMed 32815344
6. Hoel H, Heggelund L, Reikvam DH, Stiksrud B, Ueland T, Michelsen AE, Otterdal K, Muller KE, Lind A, Muller F, Dudman S, Aukrust P, Dyrhol-Riise AM, Holter JC, Trøseid M (2020)
   Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement
   J Intern Med, 289 (4), 523-531
   DOI 10.1111/joim.13178, PubMed 32976665
7. Hoel IM, Sviland L, Syre H, Dyrhol-Riise AM, Skarstein I, Jebsen P, Jørstad MD, Wiker H, Mustafa T (2020)
   Diagnosis of extrapulmonary tuberculosis using the MPT64 antigen detection test in a high-income low tuberculosis prevalence setting
   BMC Infect Dis, 20 (1), 130
   DOI 10.1186/s12879-020-4852-z, PubMed 32050915
8. Holten AR, Nore KG, Tveiten CEVWK, Olasveengen TM, Tonby K (2020)
   Predicting severe COVID-19 in the Emergency Department
   Resusc Plus, 4, 100042
   DOI 10.1016/j.resplu.2020.100042, PubMed 33403367
9. Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Tonby K, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Tollefsrud Gjølberg T, Skeie LG, Hesstvedt L, Ormåsen V, Fevang B, Austad C, Müller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, Müller F, Aukrust P et al. (2020)
   Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
   Proc Natl Acad Sci U S A, 117 (40), 25018-25025
   DOI 10.1073/pnas.2010540117, PubMed 32943538
10. Jøntvedt Jørgensen M, Holter JC, Christensen EE, Schjalm C, Tonby K, Pischke SE, Jenum S, Skeie LG, Nur S, Lind A, Opsand H, Enersen TB, Grøndahl R, Hermann A, Dudman S, Muller F, Ueland T, Mollnes TE, Aukrust P, Heggelund L, Holten AR, Dyrhol-Riise AM (2020)
    Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
    Sci Rep, 10 (1), 21697
    DOI 10.1038/s41598-020-78710-7, PubMed 33303843
11. Jøntvedt Jørgensen M, Jenum S, Tonby K, Mortensen R, Walzl G, Du Plessis N, Dyrhol-Riise AM (2020)
    Monocytic myeloid-derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase-2 inhibitors
    J Leukoc Biol, 110 (1), 177-186
    DOI 10.1002/JLB.4A0720-409RR, PubMed 33155730
12. Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, Røsjø H, Dalgard O (2020)
    Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial
    Trials, 21 (1), 485
    DOI 10.1186/s13063-020-04420-0, PubMed 32503662
13. Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rueegg CS, Rangberg A, Jonassen CM, Omland T, Røsjø H, Dalgard O (2020)
    A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
    Nat Commun, 11 (1), 5284
    DOI 10.1038/s41467-020-19056-6, PubMed 33082342
14. Mustafa T, Wergeland I, Baba K, Pathak S, Hoosen AA, Dyrhol-Riise AM (2020)
    Mycobacterial antigens in pleural fluid mononuclear cells to diagnose pleural tuberculosis in HIV co-infected patients
    BMC Infect Dis, 20 (1), 459
    DOI 10.1186/s12879-020-05165-6, PubMed 32611401
15. Nore KG, Jørgensen MJ, Dyrhol-Riise AM, Jenum S, Tonby K (2020)
    Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
    Front Immunol, 11, 579849
    DOI 10.3389/fimmu.2020.579849, PubMed 33304347
16. Reikvam DH, Meyer-Myklestad MH, Trøseid M, Stiksrud B (2020)
    Probiotics to manage inflammation in HIV infection
    Curr Opin Infect Dis, 33 (1), 34-43
    DOI 10.1097/QCO.0000000000000612, PubMed 31789692
17. Sivakumaran D, Jenum S, Vaz M, Selvam S, Ottenhoff THM, Haks MC, Malherbe ST, Doherty TM, Ritz C, Grewal HMS (2020)
    Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
    Commun Biol, 3 (1), 359
    DOI 10.1038/s42003-020-1087-x, PubMed 32647325
18. Trøseid M, Lutro O, Ormaasen V (2020)
    [Experimental treatment for COVID-19 should be undertaken in randomised studies]
    Tidsskr Nor Laegeforen, 140 (7)
    DOI 10.4045/tidsskr.20.0282, PubMed 32378863
19. Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jørgensen MJ, Barratt-Due A, Skeie LG, Nordøy I, Aanensen Fraz MS, Quist-Paulsen E E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Müller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM et al. (2020)
    Elevated plasma sTIM-3 levels in patients with severe COVID-19
    J Allergy Clin Immunol, 147 (1), 92-98
    DOI 10.1016/j.jaci.2020.09.007, PubMed 32971109
20. Ueland T, Holter JC, Holten AR, Müller KE, Lind A, Bekken GK, Dudman S, Aukrust P, Dyrhol-Riise AM, Heggelund L (2020)
    Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
    J Infect, 81 (3), e41-e43
    DOI 10.1016/j.jinf.2020.06.061, PubMed 32603675
21. Whittaker R, Nilsen O, Myrberg AJ, Angeltvedt RM, Bergersen BM, Klovstad H (2020)
    Norway is in the process of stopping the HIV epidemic
    Tidsskr. Nor. Laegeforen., 140 (18), 1864-1866

Publications 2019

1. Arnesen TM, Brantsæter AB, Nøkleby H (2019)
   Bacille Calmette-Guérin vaccination of healthcare personnel: changing epidemiology calls for new recommendations in Norway
   Eur Respir J, 53 (1)
   DOI 10.1183/13993003.01123-2018, PubMed 30630851
2. Hoel IM, Jørstad MD, Marijani M, Ruhwald M, Mustafa T, Dyrhol-Riise AM (2019)
   IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting
   Sci Rep, 9 (1), 3871
   DOI 10.1038/s41598-019-40458-0, PubMed 30846768
3. Jørstad MD, Dyrhol-Riise AM, Aßmus J, Marijani M, Sviland L, Mustafa T (2019)
   Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting
   BMC Infect Dis, 19 (1), 426
   DOI 10.1186/s12879-019-4034-z, PubMed 31096926
4. Maltezou HC, Botelho-Nevers E, Brantsæter AB, Carlsson RM, Heininger U, Hübschen JM, Josefsdottir KS, Kassianos G, Kyncl J, Ledda C, Medić S, Nitsch-Osuch A, de Lejarazu RO, Theodoridou M, Van Damme P, van Essen GA, Wicker S, Wiedermann U, Poland GA, Vaccination Policies for HCP in Europe Study Group (2019)
   Vaccination of healthcare personnel in Europe: Update to current policies
   Vaccine, 37 (52), 7576-7584
   DOI 10.1016/j.vaccine.2019.09.061, PubMed 31623916
5. Mirinaviciute G, Quist-Paulsen E, Brantsæter AB, Flem E (2019)
   The burden of herpes zoster disease in Norway
   Vaccine, 38 (18), 3501-3507
   DOI 10.1016/j.vaccine.2019.11.054, PubMed 31843267
6. Mortensen R, Clemmensen HS, Woodworth JS, Therkelsen ML, Mustafa T, Tonby K, Jenum S, Agger EM, Dyrhol-Riise AM, Andersen P (2019)
   Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
   Commun Biol, 2, 288
   DOI 10.1038/s42003-019-0530-3, PubMed 31396568
7. Quist-Paulsen E, Kran AB, Lindland ES, Ellefsen K, Sandvik L, Dunlop O, Ormaasen V (2019)
   To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
   BMC Infect Dis, 19 (1), 80
   DOI 10.1186/s12879-018-3570-2, PubMed 30669985
8. Quist-Paulsen E, Ormaasen V, Kran AB, Dunlop O, Ueland PM, Ueland T, Eikeland R, Aukrust P, Nordenmark TH (2019)
   Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning
   Sci Rep, 9 (1), 16158
   DOI 10.1038/s41598-019-52570-2, PubMed 31695095
9. Steens A, Winje BA, White RA, Odsbu I, Brantsæter AB, Vestrheim DF (2019)
   Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study
   Clin Infect Dis, 68 (8), 1367-1373
   DOI 10.1093/cid/ciy714, PubMed 30957160
10. Stiksrud B, Aass HCD, Lorvik KB, Ueland T, Trøseid M, Dyrhol-Riise AM (2019)
    Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery
    AIDS, 33 (7), 1117-1129
    DOI 10.1097/QAD.0000000000002173, PubMed 30789356
11. Storm-Larsen C, Stiksrud B, Eriksen C, Nowak P, Holm K, Thalme A, Dyrhol-Riise AM, Brix S, Hov JR, Trøseid M (2019)
    Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals
    AIDS, 33 (4), 645-653
    DOI 10.1097/QAD.0000000000002087, PubMed 30531315
12. Tonby K, Mortensen R, Ruhwald M, Dyrhol-Riise AM, Jenum S (2019)
    KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment
    J Infect Dis, 220 (1), 174-176
    DOI 10.1093/infdis/jiz056, PubMed 30888024
13. Trydal E, Martinsen AB, Beisland F, Jacobsen D, Holten AR (2019)
    [Structured evaluation on arrival of patients with sepsis and initiation of antibiotics]
    Tidsskr Nor Laegeforen, 139 (9)
    DOI 10.4045/tidsskr.18.0216, PubMed 31140244
14. Waehre T, Petterson FO (2019)
    HIV medicines on offer gives worse treatment options
    Tidsskr. Nor. Laegeforen., 139 (2), 121-122

Publications 2018

1. Habtamu M, Abebe M, Aseffa A, Dyrhol-Riise AM, Spurkland A, Abrahamsen G (2018)
   In vitro analysis of antigen induced T cell-monocyte conjugates by imaging flow cytometry
   J Immunol Methods, 460, 93-100
   DOI 10.1016/j.jim.2018.06.014, PubMed 29981305
2. Henjum K, Quist-Paulsen E, Zetterberg H, Blennow K, Nilsson LNG, Watne LO (2018)
   CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau
   J Neuroinflammation, 15 (1), 304
   DOI 10.1186/s12974-018-1331-1, PubMed 30390679
3. Jenum S, Selvam S, Jesuraj N, Ritz C, Hesseling AC, Cardenas V, Lau E, Doherty TM, Grewal HMS, Vaz M (2018)
   Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG
   BMJ Open Respir Res, 5 (1), e000304
   DOI 10.1136/bmjresp-2018-000304, PubMed 30397482
4. Jørstad MD, Marijani M, Dyrhol-Riise AM, Sviland L, Mustafa T (2018)
   MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar
   PLoS One, 13 (5), e0196723
   DOI 10.1371/journal.pone.0196723, PubMed 29742144
5. Lindland ES, Solheim AM, Andreassen S, Quist-Paulsen E, Eikeland R, Ljøstad U, Mygland Å, Elsais A, Nygaard GO, Lorentzen ÅR, Harbo HF, Beyer MK (2018)
   Imaging in Lyme neuroborreliosis
   Insights Imaging, 9 (5), 833-844
   DOI 10.1007/s13244-018-0646-x, PubMed 30187265
6. Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, Mulcahy F, Castagna A, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD, EuroSIDA Study (2018)
   Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
   AIDS, 32 (2), 205-215
   DOI 10.1097/QAD.0000000000001684, PubMed 29112060
7. Naess-Andresen K, Sorsvang L, Berntzen LS, Waehre T (2018)
   Pregnant HIV positive must be followed closely
   Tidsskr. Nor. Laegeforen., 138 (11), 998-999
8. Orlien SMS, Ismael NY, Ahmed TA, Berhe N, Lauritzen T, Roald B, Goldin RD, Stene-Johansen K, Dyrhol-Riise AM, Gundersen SG, Morgan MY, Johannessen A (2018)
   Unexplained chronic liver disease in Ethiopia: a cross-sectional study
   BMC Gastroenterol, 18 (1), 27
   DOI 10.1186/s12876-018-0755-5, PubMed 29439653
9. Pelchen-Matthews A, Ryom L, Borges ÁH, Edwards S, Duvivier C, Stephan C, Sambatakou H, Maciejewska K, Portu JJ, Weber J, Degen O, Calmy A, Reikvam DH, Jevtovic D, Wiese L, Smidt J, Smiatacz T, Hassoun G, Kuznetsova A, Clotet B, Lundgren J, Mocroft A, EuroSIDA study (2018)
   Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort
   AIDS, 32 (16), 2405-2416
   DOI 10.1097/QAD.0000000000001967, PubMed 30134296
10. Quist-Paulsen E, Aukrust P, Kran AB, Dunlop O, Ormaasen V, Stiksrud B, Midttun Ø, Ueland T, Ueland PM, Mollnes TE, Dyrhol-Riise AM (2018)
    High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
    J Neuroinflammation, 15 (1), 327
    DOI 10.1186/s12974-018-1366-3, PubMed 30470234
11. Sane Schepisi M, Navarra A, Altet Gomez MN, Dudnyk A, Dyrhol-Riise AM, Esteban J, Giorgetti PF, Gualano G, Guglielmetti L, Heyckendorf J, Kaluzhenina A, Lange B, Lange C, Manika K, Miah J, Nanovic Z, Pontali E, Prego MR, Solovic I, Tiberi S, Palmieri F, Girardi E (2018)
    Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study
    Open Forum Infect Dis, 6 (1), ofy337
    DOI 10.1093/ofid/ofy337, PubMed 30697572
12. Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, White RA, Winje BA (2018)
    Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study
    BMC Infect Dis, 18 (1), 587
    DOI 10.1186/s12879-018-3468-z, PubMed 30453946
13. Tveiten H, Brantsæter AB, Mengshoel AT (2018)
    Non-tuberculous mycobacterial pulmonary infections
    Tidsskr Nor Laegeforen, 138 (19)
    DOI 10.4045/tidsskr.18.0077, PubMed 30497255
14. Ursin Rein P, Jacobsen D, Ormaasen V, Dunlop O (2018)
    Pneumococcal sepsis requiring mechanical ventilation: Cohort study in 38 patients with rapid progression to septic shock
    Acta Anaesthesiol Scand, 62 (10), 1428-1435
    DOI 10.1111/aas.13236, PubMed 30132782
15. Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM (2018)
    Stratification by interferon-γ release assay level predicts risk of incident TB
    Thorax, 73 (7), 652-661
    DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693

Publications 2017

1. Brekke K, Sommerfelt M, Ökvist M, Dyrhol-Riise AM, Kvale D (2017)
   The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
   BMC Infect Dis, 17 (1), 228
   DOI 10.1186/s12879-017-2316-x, PubMed 28340570
2. Feruglio SL, Kvale D, Dyrhol-Riise AM (2017)
   T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis
   Scand J Immunol, 85 (2), 138-146
   DOI 10.1111/sji.12511, PubMed 27862137
3. Gjøen JE, Jenum S, Sivakumaran D, Mukherjee A, Macaden R, Kabra SK, Lodha R, Ottenhoff THM, Haks MC, Doherty TM, Ritz C, Grewal HMS (2017)
   Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children
   Sci Rep, 7 (1), 5839
   DOI 10.1038/s41598-017-05057-x, PubMed 28724962
4. Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
   Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
   PLoS One, 12 (5), e0176527
   DOI 10.1371/journal.pone.0176527, PubMed 28464042
5. van Santen DK, van der Helm JJ, Del Amo J, Meyer L, D'Arminio Monforte A, Price M, Béguelin CA, Zangerle R, Sannes M, Porter K, Geskus RB, Prins M, CASCADE Collaboration in EuroCoord (2017)
   Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014
   J Hepatol, 67 (2), 255-262
   DOI 10.1016/j.jhep.2017.03.038, PubMed 28412290

Publications 2016

1. Bates M, Brantsaeter AB (2016)
   Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
   J Virus Erad, 2 (3), 136-42
   DOI 10.1016/S2055-6640(20)30456-8, PubMed 27482452
2. Jensenius M, Winje BA, Blomberg B, Mengshoel AT, Lippe Bv, Hannula R, Bruun JN, Knudsen PK, Rønning JO, Heldal E, Dyrhol-Riise AM (2016)
   Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014
   Int J Tuberc Lung Dis, 20 (6), 786-92
   DOI 10.5588/ijtld.15.0895, PubMed 27155182
3. Jenum S, Bakken R, Dhanasekaran S, Mukherjee A, Lodha R, Singh S, Singh V, Haks MC, Ottenhoff TH, Kabra SK, Doherty TM, Ritz C, Grewal HM (2016)
   BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome
   Sci Rep, 6, 38841
   DOI 10.1038/srep38841, PubMed 27941850
4. Jenum S, Dhanasekaran S, Ritz C, Macaden R, Doherty TM, Grewal HM, TB Trials Study Group (2016)
   Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young Children
   Pediatr Infect Dis J, 35 (12), 1336-1338
   DOI 10.1097/INF.0000000000001328, PubMed 27642776
5. Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
   Hepatitis C reinfection after sustained virological response
   J Hepatol, 64 (5), 1020-1026
   DOI 10.1016/j.jhep.2016.01.001, PubMed 26780289
6. Prebensen C, Lind A, Dyrhol-Riise AM, Kvale D (2016)
   Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
   PLoS One, 11 (4), e0153849
   DOI 10.1371/journal.pone.0153849, PubMed 27128502
7. Stiksrud B, Lorvik KB, Kvale D, Mollnes TE, Ueland PM, Trøseid M, Taskén K, Dyrhol-Riise AM (2016)
   Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts
   J Acquir Immune Defic Syndr, 73 (2), 138-48
   DOI 10.1097/QAI.0000000000001080, PubMed 27632144
8. Tonby K, Wergeland I, Lieske NV, Kvale D, Tasken K, Dyrhol-Riise AM (2016)
   The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
   BMC Infect Dis, 16 (1), 599
   DOI 10.1186/s12879-016-1938-8, PubMed 27776487
9. Uyeki TM, Mehta AK, Davey RT, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J, Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe (2016)
   Clinical Management of Ebola Virus Disease in the United States and Europe
   N Engl J Med, 374 (7), 636-46
   DOI 10.1056/NEJMoa1504874, PubMed 26886522
10. Wergeland I, Assmus J, Dyrhol-Riise AM (2016)
    Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
    PLoS One, 11 (9), e0163848
    DOI 10.1371/journal.pone.0163848, PubMed 27685462

Publications 2015

1. Feruglio SL, Tonby K, Kvale D, Dyrhol-Riise AM (2015)
   Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
   Clin Exp Immunol, 179 (3), 454-65
   DOI 10.1111/cei.12468, PubMed 25313008
2. Gaardbo JC, Trøsied M, Stiksrud B, Midttun Ø, Ueland PM, Ullum H, Nielsen SD (2015)
   Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up
   J Acquir Immune Defic Syndr, 70 (3), 228-35
   DOI 10.1097/QAI.0000000000000758, PubMed 26470032
3. Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M et al. (2015)
   Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
   Clin Infect Dis, 62 (5), 655-663
   DOI 10.1093/cid/civ963, PubMed 26620652
4. Haabeth OA, Lorvik KB, Yagita H, Bogen B, Corthay A (2015)
   Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
   Oncoimmunology, 5 (1), e1039763
   DOI 10.1080/2162402X.2015.1039763, PubMed 26942052
5. Lieske NV, Tonby K, Kvale D, Dyrhol-Riise AM, Tasken K (2015)
   Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
   PLoS One, 10 (11), e0141903
   DOI 10.1371/journal.pone.0141903, PubMed 26544592
6. Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D (2015)
   High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
   J Acquir Immune Defic Syndr, 69 (4), 395-402
   DOI 10.1097/QAI.0000000000000617, PubMed 26115437
7. Riise AMD (2015)
   Our Voices HIV: 30 years in Norway
   Tidsskr. Nor. Laegeforen., 135 (19), 1769
   DOI 10.4045/tidsskr.15.0785
8. Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
   Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
   J Acquir Immune Defic Syndr, 70 (4), 329-37
   DOI 10.1097/QAI.0000000000000784, PubMed 26258571
9. Tonby K, Ruhwald M, Kvale D, Dyrhol-Riise AM (2015)
   IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
   Sci Rep, 5, 9223
   DOI 10.1038/srep09223, PubMed 25783975
10. Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, Kvale D, Damås JK, Aukrust P, Mollnes TE, Dyrhol-Riise AM (2015)
    IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
    J Infect, 70 (4), 381-91
    DOI 10.1016/j.jinf.2014.12.019, PubMed 25597826

Publications 2014

1. Brekke K, Lind A, Holm-Hansen C, Haugen IL, Sørensen B, Sommerfelt M, Kvale D (2014)
   Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial
   PLoS One, 9 (11), e112556
   DOI 10.1371/journal.pone.0112556, PubMed 25398137
2. Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F (2014)
   Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
   Genome Biol, 15 (11), 490
   DOI 10.1186/s13059-014-0490-3, PubMed 25418686
3. Hesstvedt L, Reikvam DH, Dunlop O (2014)
   Neurological melioidosis in Norway presenting with a cerebral abscess
   IDCases, 2 (1), 16-8
   DOI 10.1016/j.idcr.2014.11.001, PubMed 26793441
4. Lind A, Brekke K, Pettersen FO, Mollnes TE, Trøseid M, Kvale D (2014)
   A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
   PLoS One, 9 (1), e85604
   DOI 10.1371/journal.pone.0085604, PubMed 24416431
5. Maeland A (2014)
   Antiretroviral treatment initiation
   Lancet Infect Dis, 14 (12), 1175
   DOI 10.1016/S1473-3099(14)70947-8, PubMed 25455976
6. Manner IW, Baekken M, Oektedalen O, Kvale D, Nowak P, Nielsen SD, Os I, Trøseid M (2014)
   Plasma lipopolysaccharide and triglycerides are independently associated and both markers correlate with the development of metabolic syndrome in HIV infection
   J Acquir Immune Defic Syndr, 65 (4), e158-61
   DOI 10.1097/QAI.0000000000000055, PubMed 24577189
7. Mocroft A, Ryom L, Begovac J, Monforte AD, Vassilenko A, Gatell J, Florence E, Ormaasen V, Kirk O, Lundgren JD, EuroSIDA in EuroCOORD (2014)
   Deteriorating renal function and clinical outcomes in HIV-positive persons
   AIDS, 28 (5), 727-37
   DOI 10.1097/QAD.0000000000000134, PubMed 24983543
8. Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, Lodi S, Ghosn J, Dorrucci M, Johnson A, Sannes M, Moreno S, Porter K, for CASCADE Collaboration in EuroCoord (2014)
   Evaluation of rapid progressors in HIV infection as an extreme phenotype
   J Acquir Immune Defic Syndr, 67 (1), 15-21
   DOI 10.1097/QAI.0000000000000240, PubMed 24872130
9. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
   Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
   J Acquir Immune Defic Syndr, 67 (4), 370-4
   DOI 10.1097/QAI.0000000000000339, PubMed 25226210
10. Pettersen PS, Brox IK, Naman E, Bruun JN, Dyrhol-Riise AM, Trøseid M, Johannessen A (2014)
    Antiretroviral treatment failure predicts mortality in rural Tanzania
    Int J STD AIDS, 26 (9), 633-9
    DOI 10.1177/0956462414548460, PubMed 25122578
11. Pullar ND, Steinum H, Tonby K, Heggelund L, Leiva RA, Ofstad R, Bruun JN, Dyrhol-Riise AM (2014)
    Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway
    Int J Tuberc Lung Dis, 18 (2), 180-7
    DOI 10.5588/ijtld.13.0276, PubMed 24429310
12. Trøseid M, Ditlevsen S, Hvid T, Gerstoft J, Grøndahl T, Pedersen BK, Nielsen SD, Lindegaard B (2014)
    Reduced trunk fat and triglycerides after strength training are associated with reduced LPS levels in HIV-infected individuals
    J Acquir Immune Defic Syndr, 66 (2), e52-4
    DOI 10.1097/QAI.0000000000000132, PubMed 24608893
13. Trøseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD (2014)
    Microbial translocation and cardiometabolic risk factors in HIV infection
    AIDS Res Hum Retroviruses, 30 (6), 514-22
    DOI 10.1089/aid.2013.0280, PubMed 24521167
14. Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A (2014)
    Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
    J Intern Med, 277 (6), 717-26
    DOI 10.1111/joim.12328, PubMed 25382824
15. Wæhre T, Maagard A, Tappe D, Cadar D, Schmidt-Chanasit J (2014)
    Zika virus infection after travel to Tahiti, December 2013
    Emerg Infect Dis, 20 (8), 1412-4
    DOI 10.3201/eid2008.140302, PubMed 25062427

Publications 2013

1. Andersson LM, Vesterbacka J, Blaxhult A, Flamholc L, Nilsson S, Ormaasen V, Sönnerborg A, Gisslén M (2013)
   Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial
   Scand J Infect Dis, 45 (7), 543-51
   DOI 10.3109/00365548.2012.756985, PubMed 23294034
2. Cornez I, Joel M, Taskén K, Langmoen IA, Glover JC, Berge T (2013)
   EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry
   J Neurooncol, 112 (1), 49-57
   DOI 10.1007/s11060-012-1035-9, PubMed 23299461
3. Drozd F, Skeie LG, Kraft P, Kvale D (2013)
   A web-based intervention trial for depressive symptoms and subjective well-being in patients with chronic HIV infection
   AIDS Care, 26 (9), 1080-9
   DOI 10.1080/09540121.2013.869541, PubMed 24359563
4. Feruglio SL, Trøseid M, Damås JK, Kvale D, Dyrhol-Riise AM (2013)
   Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses
   PLoS One, 8 (7), e69896
   DOI 10.1371/journal.pone.0069896, PubMed 23875007
5. Haugaard AK, Lund TT, Birch C, Rönsholt F, Trøseid M, Ullum H, Gerstoft J, Johansson PI, Nielsen SD, Ostrowski SR (2013)
   Discrepant coagulation profile in HIV infection: elevated D-dimer but impaired platelet aggregation and clot initiation
   AIDS, 27 (17), 2749-58
   DOI 10.1097/01.aids.0000432462.21723.ed, PubMed 23842126
6. Landskron J, Taskén K (2013)
   CD147 in regulatory T cells
   Cell Immunol, 282 (1), 17-20
   DOI 10.1016/j.cellimm.2013.04.008, PubMed 23665204
7. Lind A, Brekke K, Sommerfelt M, Holmberg JO, Aass HC, Baksaas I, Sørensen B, Dyrhol-Riise AM, Kvale D (2013)
   Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
   Vaccine, 31 (41), 4611-8
   DOI 10.1016/j.vaccine.2013.07.037, PubMed 23906886
8. MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BA, Jonsrud K, Lundgren B, Mellegard H, Moller-Stray J, Ronning K, Vestrheim DF, Vold L (2013)
   Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013
   Eurosurveillance, 18 (45), 2-5
9. MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BÅ, Jonsrud K, Lundgren B, Mellegård H, Møller-Stray J, Rønning K, Vestrheim DF, Vold L (2013)
   Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013
   Euro Surveill, 18 (45), 20630
   DOI 10.2807/1560-7917.es2013.18.45.20630, PubMed 24229788
10. Madec Y, Boufassa F, Porter K, Prins M, Sabin C, d'Arminio Monforte A, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L, CASCADE Collaboration in Eurocoord (2013)
    Natural history of HIV-control since seroconversion
    AIDS, 27 (15), 2451-60
    DOI 10.1097/01.aids.0000431945.72365.01, PubMed 23912979
11. Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Trøseid M (2013)
    Markers of microbial translocation predict hypertension in HIV-infected individuals
    HIV Med, 14 (6), 354-61
    DOI 10.1111/hiv.12015, PubMed 23332095
12. Pedersen KK, Pedersen M, Trøseid M, Gaardbo JC, Lund TT, Thomsen C, Gerstoft J, Kvale D, Nielsen SD (2013)
    Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction
    J Acquir Immune Defic Syndr, 64 (5), 425-33
    DOI 10.1097/QAI.0b013e31829f919d, PubMed 23797689
13. Ushakova A, Pettersen FO, Mæland A, Lindqvist BH, Kvale D (2013)
    Bayesian estimation of HIV-1 dynamics in vivo
    Math Med Biol, 32 (1), 38-55
    DOI 10.1093/imammb/dqt018, PubMed 24078026
14. Vang T, Landskron J, Viken MK, Oberprieler N, Torgersen KM, Mustelin T, Tasken K, Tautz L, Rickert RC, Lie BA (2013)
    The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses
    Hum Immunol, 74 (5), 574-85
    DOI 10.1016/j.humimm.2012.12.017, PubMed 23333624

Publications 2012

1. Brantsæter AB (2012)
   [Malaria treatment--herbal therapy in new clothes]
   Tidsskr Nor Laegeforen, 132 (6), 614
   DOI 10.4045/tidsskr.12.0238, PubMed 22456126
2. Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
   Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
   Int J Infect Dis, 16 (12), e879-85
   DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419
3. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
   Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
   J Acquir Immune Defic Syndr, 59 (2), e24-5
   DOI 10.1097/QAI.0b013e31823f35a7, PubMed 22245717
4. Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
   Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
   Clin Exp Immunol, 167 (3), 492-8
   DOI 10.1111/j.1365-2249.2011.04524.x, PubMed 22288592
5. De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G, European Network for Highly Infectious Diseases Working Group (2012)
   Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries
   Infect Control Hosp Epidemiol, 33 (10), 1008-16
   DOI 10.1086/667729, PubMed 22961020
6. Kalland ME, Solheim SA, Skånland SS, Taskén K, Berge T (2012)
   Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG
   Exp Cell Res, 318 (14), 1611-9
   DOI 10.1016/j.yexcr.2012.05.014, PubMed 22659621
7. Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D (2012)
   Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
   Scand J Infect Dis, 44 (8), 566-72
   DOI 10.3109/00365548.2011.653581, PubMed 22339485
8. Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, Porter K (2012)
   Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
   Arch Intern Med, 172 (16), 1252-5
   DOI 10.1001/archinternmed.2012.2719, PubMed 22826124
9. Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
   Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
   J Clin Hypertens (Greenwich), 15 (2), 101-6
   DOI 10.1111/jch.12029, PubMed 23339727
10. Nowak P, Abdurahman S, Lindkvist A, Troseid M, Sönnerborg A (2012)
    Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
    Int J Microbiol, 2012, 263836
    DOI 10.1155/2012/263836, PubMed 22719767
11. Nowak P, Nystrom J, Troseid M (2012)
    High levels of HMGB1 in plasma may be due to ex vivo cell necrosis
    Anticancer Res, 32 (9), 4067-9
    PubMed 22993362
12. Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
    Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
    Arterioscler Thromb Vasc Biol, 33 (2), e47-55
    DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017
13. Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
    Infectious encephalitis: a description of a Norwegian cohort
    Scand J Infect Dis, 45 (3), 179-85
    DOI 10.3109/00365548.2012.719634, PubMed 23113672
14. Rekić D, Röshammar D, Bergstrand M, Tarning J, Calcagno A, D'Avolio A, Ormaasen V, Vigan M, Barrail-Tran A, Ashton M, Gisslén M, Äbelö A (2012)
    External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
    AAPS J, 15 (2), 308-15
    DOI 10.1208/s12248-012-9440-8, PubMed 23224752
15. Scott JD, Dessauer CW, Taskén K (2012)
    Creating order from chaos: cellular regulation by kinase anchoring
    Annu Rev Pharmacol Toxicol, 53, 187-210
    DOI 10.1146/annurev-pharmtox-011112-140204, PubMed 23043438
16. Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
    Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
    Innate Immun, 19 (3), 290-7
    DOI 10.1177/1753425912461042, PubMed 23070967
17. Wessman M, Westling K, Aho I, Quist-Paulsen E, Wæhre T, Rolfhamre L, Weis N, Katzenstein TL (2012)
    Major differences in assisted reproductive treatments offered to HIV-1 infected patients in the Nordic countries
    Scand J Infect Dis, 44 (5), 402-4
    DOI 10.3109/00365548.2011.649491, PubMed 22292615

Publications 2011

1. Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
   Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
   J Infect, 63 (4), 308-16
   DOI 10.1016/j.jinf.2011.07.004, PubMed 21781987
2. Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
   Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
   BMC Infect Dis, 11, 75
   DOI 10.1186/1471-2334-11-75, PubMed 21435254
3. Brantsæter AB (2011)
   [Did vaccines and hygiene recommendations affect the pandemic?]
   Tidsskr Nor Laegeforen, 131 (7), 662
   DOI 10.4045/tidsskr.11.0318, PubMed 21494288
4. Corthay A, Lorvik KB, Bogen B (2011)
   Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer
   Scand J Immunol, 73 (6), 527-30
   DOI 10.1111/j.1365-3083.2011.02558.x, PubMed 21388431
5. Hesstvedt L, Wilhelmsen M, Mengshoel AT, Dyrhol-Riise AM (2011)
   Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses
   J Travel Med, 18 (6), 418-21
   DOI 10.1111/j.1708-8305.2011.00550.x, PubMed 22017720
6. Kivuyo SL, Johannessen A, Trøseid M, Kasubi MJ, Gundersen SG, Naman E, Mushi D, Ngowi BJ, Mfinanga GS, Bruun JN (2011)
   p24 antigen detection on dried blood spots is a feasible and reliable test for infant HIV infection in rural Tanzania
   Int J STD AIDS, 22 (12), 719-21
   DOI 10.1258/ijsa.2009.009382, PubMed 22174052
7. Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2011)
   Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
   APMIS, 120 (3), 204-9
   DOI 10.1111/j.1600-0463.2011.02843.x, PubMed 22339677
8. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
   An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
   J Virol, 85 (13), 6557-66
   DOI 10.1128/JVI.00073-11, PubMed 21490090
9. Rekić D, Clewe O, Röshammar D, Flamholc L, Sönnerborg A, Ormaasen V, Gisslén M, Abelö A, Ashton M (2011)
   Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy
   AAPS J, 13 (4), 598-605
   DOI 10.1208/s12248-011-9299-0, PubMed 21913053
10. Röshammar D, Simonsson US, Ekvall H, Flamholc L, Ormaasen V, Vesterbacka J, Wallmark E, Ashton M, Gisslén M (2011)
    Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients
    J Pharmacokinet Pharmacodyn, 38 (6), 727-42
    DOI 10.1007/s10928-011-9217-1, PubMed 21964996
11. Trøseid M (2011)
    [The fight against HIV--two scenarios]
    Tidsskr Nor Laegeforen, 131 (23), 2331
    DOI 10.4045/tidsskr.11.1213, PubMed 22139097
12. Trøseid M, Sönnerborg A, Nowak P (2011)
    High mobility group box protein-1 in HIV-1 infection
    Curr HIV Res, 9 (1), 6-10
    DOI 10.2174/157016211794582632, PubMed 21198433
13. van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB, CASCADE Collaboration (2011)
    The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007
    AIDS, 25 (8), 1083-91
    DOI 10.1097/QAD.0b013e3283471cce, PubMed 21537114

Publications 2010

1. Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
   Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
   J Acquir Immune Defic Syndr, 53 (3), 419-20
   DOI 10.1097/QAI.0b013e3181ba4101, PubMed 20190590
2. Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN (2010)
   Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital
   J Antimicrob Chemother, 65 (9), 1996-2000
   DOI 10.1093/jac/dkq234, PubMed 20576637
3. Edén A, Andersson LM, Andersson O, Flamholc L, Josephson F, Nilsson S, Ormaasen V, Svedhem V, Säll C, Sönnerborg A, Tunbäck P, Gisslén M (2010)
   Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients
   AIDS Res Hum Retroviruses, 26 (5), 533-40
   DOI 10.1089/aid.2009.0177, PubMed 20455766
4. Grydeland H, Walhovd KB, Westlye LT, Due-Tønnessen P, Ormaasen V, Sundseth Ø, Fjell AM (2010)
   Amnesia following herpes simplex encephalitis: diffusion-tensor imaging uncovers reduced integrity of normal-appearing white matter
   Radiology, 257 (3), 774-81
   DOI 10.1148/radiol.10100179, PubMed 20935078
5. Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
   [Syphilis and blood transfusion]
   Tidsskr Nor Laegeforen, 130 (8), 839-41
   DOI 10.4045/tidsskr.08.0188, PubMed 20418930
6. Johannessen A, Holberg-Petersen M, Lövgaarden G, Naman E, Ormaasen V, Matee MI, Gundersen SG, Bruun JN (2010)
   HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania
   Antivir Ther, 15 (7), 1003-9
   DOI 10.3851/IMP1660, PubMed 21041915
7. Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010)
   Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
   AIDS, 24 (17), 2609-18
   DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558
8. Pettersen FO, Taskén K, Kvale D (2010)
   Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection
   Clin Exp Immunol, 161 (2), 315-23
   DOI 10.1111/j.1365-2249.2010.04179.x, PubMed 20491784

Publications 2009

1. Brantsaeter AB (2009)
   [An underestimated throat bacteria]
   Tidsskr Nor Laegeforen, 129 (17), 1756
   DOI 10.4045/tidsskr.09.0788, PubMed 19756058
2. Hauge SH, Dudman SG, Borgen K, Hungnes O, Brantsaeter A, Iversen B, Aavitsland P (2009)
   [Disease caused by the new influenza A(H1N1) virus]
   Tidsskr Nor Laegeforen, 129 (17), 1736-9
   DOI 10.4045/tidsskr.09.0748, PubMed 19756053
3. Josephson F, Andersson MC, Flamholc L, Gisslén M, Hagberg L, Ormaasen V, Sönnerborg A, Vesterbacka J, Böttiger Y (2009)
   The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
   Eur J Clin Pharmacol, 66 (4), 349-57
   DOI 10.1007/s00228-009-0763-z, PubMed 19967342
4. Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
   Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
   J Clin Microbiol, 47 (7), 2170-4
   DOI 10.1128/JCM.00519-09, PubMed 19420166
5. Maagaard A, Kvale D (2009)
   Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
   J Antimicrob Chemother, 64 (5), 901-9
   DOI 10.1093/jac/dkp316, PubMed 19740910
6. Maagaard A, Kvale D (2009)
   Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity
   Scand J Infect Dis, 41 (11-12), 808-17
   DOI 10.3109/00365540903186181, PubMed 19922062
7. Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kücherer C, Leitner T et al. (2009)
   Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
   Retrovirology, 6, 49
   DOI 10.1186/1742-4690-6-49, PubMed 19457244
8. Sandanger Ø, Ryan L, Bohnhorst J, Iversen AC, Husebye H, Halaas Ø, Landrø L, Aukrust P, Frøland SS, Elson G, Visintin A, Øktedalen O, Damås JK, Sundan A, Golenbock D, Espevik T (2009)
   IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients
   J Immunol, 182 (1), 588-95
   DOI 10.4049/jimmunol.182.1.588, PubMed 19109192
9. Skeie L, Bugge H, Negaard A, Bergersen BM (2009)
   Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study
   HIV Med, 11 (3), 170-7
   DOI 10.1111/j.1468-1293.2009.00761.x, PubMed 19780861
10. Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM (2009)
    Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population
    Eur J Immunol, 39 (5), 1280-7
    DOI 10.1002/eji.200839002, PubMed 19384871

Publications 2008

1. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K, CASCADE Collaboration (2008)
   Changes in the risk of death after HIV seroconversion compared with mortality in the general population
   JAMA, 300 (1), 51-9
   DOI 10.1001/jama.300.1.51, PubMed 18594040
2. Bjark P, Ormaasen V, Skjelmerud T (2008)
   [Treatment of erythema migrans]
   Tidsskr Nor Laegeforen, 128 (24), 2844
   PubMed 19092956
3. Brantsaeter AB (2008)
   [Action against tuberculosis--all has its time]
   Tidsskr Nor Laegeforen, 128 (24), 2817
   PubMed 19092946
4. Holm M, Pettersen FO, Kvale D (2008)
   PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples
   Curr HIV Res, 6 (1), 49-58
   DOI 10.2174/157016208783571955, PubMed 18288975
5. Josephson F, Bertilsson L, Böttiger Y, Flamholc L, Gisslén M, Ormaasen V, Sönnerborg A, Diczfalusy U (2008)
   CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels
   Eur J Clin Pharmacol, 64 (8), 775-81
   DOI 10.1007/s00228-008-0492-8, PubMed 18458892
6. Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008)
   Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
   J Infect Dis, 198 (10), 1474-81
   DOI 10.1086/592713, PubMed 18851688

Publications 2007

1. Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN (2007)
   CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study
   BMC Infect Dis, 7, 127
   DOI 10.1186/1471-2334-7-127, PubMed 17986346
2. Bugge H, Negaard A, Skeie L, Bergersen B (2007)
   Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients
   HIV Med, 8 (8), 475-82
   DOI 10.1111/j.1468-1293.2007.00494.x, PubMed 17944679
3. Jensenius M, Berild D, Ormaasen V, Maehlen J, Lindegren G, Falk KI (2007)
   Fatal subarachnoidal haemorrhage in a Norwegian traveller with dengue virus infection
   Scand J Infect Dis, 39 (3), 272-4
   DOI 10.1080/00365540600891307, PubMed 17366065
4. Jensenius M, Maeland A, Brubakk O (2007)
   Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics
   Travel Med Infect Dis, 6 (1-2), 45-7
   DOI 10.1016/j.tmaid.2007.09.043, PubMed 18342274
5. Maagaard A, Holberg-Petersen M, Torjesen PA, Bruun JN, Kvale D (2007)
   Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients
   HIV Clin Trials, 8 (5), 345-53
   DOI 10.1310/hct0805-345, PubMed 17956836

Publications 2006

1. Bergersen BM (2006)
   Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy
   Drugs, 66 (15), 1971-87
   DOI 10.2165/00003495-200666150-00006, PubMed 17100407
2. Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
   Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
   Scand J Infect Dis, 38 (8), 682-9
   DOI 10.1080/00365540500361302, PubMed 16857615
3. Brantsaeter AB (2006)
   [Tularemia]
   Tidsskr Nor Laegeforen, 126 (8), 1034
   PubMed 16619059
4. Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
   [HIV/AIDS--from lethal syndrome to chronic disease]
   Tidsskr Nor Laegeforen, 126 (23), 3121-4
   PubMed 17160119
5. Kran AM, Kvale D (2006)
   [Immunopathogenesis and therapeutic immunization in HIV-infection]
   Tidsskr Nor Laegeforen, 126 (23), 3112-6
   PubMed 17160117
6. Kran AM, Sørensen B, Sommerfelt MA, Nyhus J, Baksaas I, Kvale D (2006)
   Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
   AIDS, 20 (4), 627-30
   DOI 10.1097/01.aids.0000210620.75707.ac, PubMed 16470131
7. Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006)
   Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
   AIDS, 20 (6), 813-20
   DOI 10.1097/01.aids.0000218544.54586.f1, PubMed 16549964
8. Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN (2006)
   Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
   Antivir Ther, 11 (5), 601-8
   PubMed 16964828
9. Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN (2006)
   Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients
   HIV Med, 7 (1), 53-8
   DOI 10.1111/j.1468-1293.2005.00336.x, PubMed 16313293
10. Nygård K, Brantsaeter A, Feruglio S, Ravn J, Dotevall L, Hasle G, Myrvang B (2006)
    [Histoplasmosis among travellers to Central America]
    Tidsskr Nor Laegeforen, 126 (21), 2838-42
    PubMed 17086244
11. Skeie L, Maeland A (2006)
    Can efavirenz be taken in the morning?
    Scand J Infect Dis, 38 (11-12), 1089-91
    DOI 10.1080/00365540600794386, PubMed 17148083
12. van de Vijver DA, Wensing AM, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2006)
    The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
    J Acquir Immune Defic Syndr, 41 (3), 352-60
    DOI 10.1097/01.qai.0000209899.05126.e4, PubMed 16540937

Publications 2005

1. Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
   Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
   Haematologica, 90 (1), 86-93
   PubMed 15642674
2. Bergersen BM, Sandvik L, Ellingsen I, Bruun JN (2005)
   Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive
   HIV Med, 6 (4), 260-7
   DOI 10.1111/j.1468-1293.2005.00305.x, PubMed 16011531
3. Blystad H, Brantsaeter AB, Lovoll Ø (2005)
   Outbreak of community-acquired legionnaires disease in southeast Norway, May 2005
   Euro Surveill, 10 (5), E050526.1
   PubMed 16770016
4. Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G (2005)
   Treatment outcome of new culture positive pulmonary tuberculosis in Norway
   BMC Public Health, 5, 14
   DOI 10.1186/1471-2458-5-14, PubMed 15698472
5. Kran AM, Sommerfelt MA, Sørensen B, Nyhus J, Baksaas I, Bruun JN, Kvale D (2005)
   Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
   Vaccine, 23 (31), 4011-5
   DOI 10.1016/j.vaccine.2005.03.010, PubMed 15963359
6. Kvale D, Kran AM, Sommerfelt MA, Nyhus J, Baksaas I, Bruun JN, Sørensen B (2005)
   Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia
   AIDS, 19 (6), 563-7
   DOI 10.1097/01.aids.0000163932.76531.c6, PubMed 15802974
7. Nygård K, Brantsaeter AB, Mehl R (2005)
   Disseminated and chronic Lyme borreliosis in Norway, 1995 - 2004
   Euro Surveill, 10 (10), 235-8
   PubMed 16282646
8. Nyhus J, Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2005)
   Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
   Vaccine, 24 (10), 1543-50
   DOI 10.1016/j.vaccine.2005.10.012, PubMed 16289707
9. Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2005)
   Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
   J Infect Dis, 192 (6), 958-66
   DOI 10.1086/432916, PubMed 16107947

Publications 2004

1. Cook CC, Brekke K (2004)
   Productivity preservation through hydraulic propped fractures in the Eldfisk North Sea chalk field
   SPE Reserv. Eval. Eng., 7 (2), 105-114
   DOI 10.2118/88031-PA
2. Kran AM, Sørensen B, Nyhus J, Sommerfelt MA, Baksaas I, Bruun JN, Kvale D (2004)
   HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
   AIDS, 18 (14), 1875-83
   DOI 10.1097/00002030-200409240-00003, PubMed 15353973
3. Lugada ES, Mermin J, Asjo B, Kaharuza F, Downing R, Langeland N, Ormaasen V, Bruun J, Awor AC, Ulvestad E (2004)
   Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway
   Scand J Immunol, 59 (2), 203-8
   DOI 10.1111/j.0300-9475.2004.01376.x, PubMed 14871298
4. Nilssen DE, Øktedalen O, Brandtzaeg P (2004)
   Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy
   Gut, 53 (4), 487-93
   DOI 10.1136/gut.2003.027854, PubMed 15016741